Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,199 public trials 263 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Active, Not Recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

NCT06111235

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Urology Centers of Alabama PC Homewood, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Institute of Urology PLLC Tucson, Arizona, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

NCT03924895

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 1582) Mobile, Alabama, United States
  • CARTI Cancer Center ( Site 1577) Little Rock, Arkansas, United States
  • St. Joseph Heritage Healthcare ( Site 0046) Fullerton, California, United States
  • Scripps MD Anderson ( Site 0010) La Jolla, California, United States
View all 242 locations
View Trial Details
Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details
Active, Not Recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • AOA-HOPE Tucson, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • HOAG Memorial Hospital Presbyterian Newport, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +55 more
Locations
  • Hoag Memorial Presbyterian Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care East Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

NCT03768570

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Health Sciences North Greater Sudbury, Ontario, Canada
View all 31 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

NCT05092958

Conditions
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, +30 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
View all 275 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

NCT03854474

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

NCT03375307

Conditions
Advanced Bladder Carcinoma, Advanced Genitourinary System Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • UC San Diego Health System - Encinitas Encinitas, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details

Related conditions